Baird Financial Group, Inc.

SEC CIK: 0001648711
Latest filing: Aug 12, 2026

SEC filings (opens in a new tab)

ACAD holding history

Acadia Pharmaceuticals Inc in every 13F filed by Baird Financial Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACAD overview All 13F holders of ACAD Full Q2 2026 holdings

Shares (Q2 2026): 9,163
Value: $231.8K
% of portfolio: <0.1%
Quarters held: 2; Since Q1 2025

Holdings of ACAD by Baird Financial Group, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	9,163	$231.8K	<0.1%	+9,163	New	Holders
Q2 2025	0	$0	0.0%	−90,864−100.0%	Sold out	Holders
Q1 2025	90,864	$1.51M	<0.1%	+90,864	New	Holders